Genetically Predicted Causal Effects of Gut Microbiota on Spinal Pain: a Two-sample Mendelian Randomization Analysis

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2024 Apr 9

PMID 38591041

Authors

Shuangwei Hong

Longhao Chen

Xingchen Zhou

Yuanshen Huang

Yu Tian

Huijie Hu

Bei Yu

Hongjiao Wu

Chao Yang

Zhizhen Lv

Lijiang Lv

Affiliations

Soon will be listed here.

Abstract

Background: Observational studies have hinted at a correlation between the gut microbiota and spinal pain (SP). However, the impact of the gut microbiota on SP remains inconclusive.

Methods: In this study, we employed a two-sample Mendelian randomization (MR) analysis to explore the causal relationship between the gut microbiota and SP, encompassing neck pain (NP), thoracic spine pain (TSP), low back pain (LBP), and back pain (BP). The compiled gut microbiota data originated from a genome-wide association study (GWAS) conducted by the MiBioGen consortium ( = 18,340). Summary data for NP were sourced from the UK Biobank, TSP from the FinnGen Biobank, and LBP from both the UK Biobank and FinnGen Biobank. Summary data for BP were obtained from the UK Biobank. The primary analytical approach for assessing causal relationships was the Inverse Variance Weighted (IVW) method, supplemented by various sensitivity analyses to ensure result robustness.

Results: The IVW analysis unveiled 37 bacterial genera with a potential causal relationship to SP. After Benjamini-Hochberg corrected test, four bacterial genera emerged with a strong causal relationship to SP. Specifically, (OR: 1.143, 95% CI 1.061-1.232, = 0.0004) and (OR: 1.145, 95% CI 1.059-1.238, = 0.0007) were identified as risk factors for LBP, while (OR: 0.859, 95% CI 0.791-0.932, = 0.0003) was marked as a protective factor for LBP, and (OR: 0.893, 95% CI 0.839-0.951, = 0.0004) was recognized as a protective factor for low back pain or/and sciatica. No significant heterogeneity or horizontal pleiotropy was observed through alternative testing methods.

Conclusion: This study establishes a causal relationship between the gut microbiota and SP, shedding light on the "gut-spine" axis. These findings offer novel perspectives for understanding the etiology of SP and provide a theoretical foundation for potential interventions targeting the gut microbiota to prevent and treat SP.

Citing Articles

Causal relationships of gut microbiota and blood metabolites with ovarian cancer and endometrial cancer: a Mendelian randomization study.

Chen J, Chen X, Ma J J Ovarian Res. 2025; 18(1):54.

PMID: 40082983 PMC: 11905533. DOI: 10.1186/s13048-025-01630-5.

Causal relationship between immune cells and pulmonary arterial hypertension: Mendelian randomization analysis.

Du D, Qiu J, Zhao J, Yuan Y Medicine (Baltimore). 2024; 103(37):e39670.

PMID: 39287266 PMC: 11404942. DOI: 10.1097/MD.0000000000039670.

References

Ruuskanen M, Erawijantari P, Havulinna A, Liu Y, Meric G, Tuomilehto J . Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults. Diabetes Care. 2022; 45(4):811-818. PMC: 9016732. DOI: 10.2337/dc21-2358. View

Davey Smith G, Ebrahim S . 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol. 2003; 32(1):1-22. DOI: 10.1093/ije/dyg070. View

de Luca K, Tavares P, Yang H, Hurwitz E, Green B, Dale H . Spinal Pain, Chronic Health Conditions and Health Behaviors: Data from the 2016-2018 National Health Interview Survey. Int J Environ Res Public Health. 2023; 20(7). PMC: 10094294. DOI: 10.3390/ijerph20075369. View

Manchikanti L, Boswell M, Singh V, Pampati V, Damron K, Beyer C . Prevalence of facet joint pain in chronic spinal pain of cervical, thoracic, and lumbar regions. BMC Musculoskelet Disord. 2004; 5:15. PMC: 441387. DOI: 10.1186/1471-2474-5-15. View

Burgess S, Bowden J, Fall T, Ingelsson E, Thompson S . Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants. Epidemiology. 2016; 28(1):30-42. PMC: 5133381. DOI: 10.1097/EDE.0000000000000559. View

Lin K, Zhu L, Yang L . Gut and obesity/metabolic disease: Focus on microbiota metabolites. MedComm (2020). 2022; 3(3):e171. PMC: 9437302. DOI: 10.1002/mco2.171. View

Tang Y, Du J, Wu H, Wang M, Liu S, Tao F . Potential Therapeutic Effects of Short-Chain Fatty Acids on Chronic Pain. Curr Neuropharmacol. 2022; 22(2):191-203. PMC: 10788890. DOI: 10.2174/1570159X20666220927092016. View

Burgess S, Dudbridge F, Thompson S . Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2015; 35(11):1880-906. PMC: 4832315. DOI: 10.1002/sim.6835. View

Xie L, Zhao H, Chen W . Relationship between gut microbiota and thyroid function: a two-sample Mendelian randomization study. Front Endocrinol (Lausanne). 2023; 14:1240752. PMC: 10562735. DOI: 10.3389/fendo.2023.1240752. View

10.

Clark J, Coopersmith C . Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock. 2007; 28(4):384-93. PMC: 2084394. DOI: 10.1097/shk.0b013e31805569df. View

11.

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

12.

Sugiyama Y, Mori Y, Nara M, Kotani Y, Nagai E, Kawada H . Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production. Gut Microbes. 2022; 14(1):2128605. PMC: 9553188. DOI: 10.1080/19490976.2022.2128605. View

13.

Akagawa S, Kaneko K . Gut microbiota and allergic diseases in children. Allergol Int. 2022; 71(3):301-309. DOI: 10.1016/j.alit.2022.02.004. View

14.

Meng Q, Liu K, Liu Z, Liu J, Tian Z, Qin S . Digoxin protects against intervertebral disc degeneration via TNF/NF-κB and LRP4 signaling. Front Immunol. 2023; 14:1251517. PMC: 10544936. DOI: 10.3389/fimmu.2023.1251517. View

15.

Koes B, van Tulder M, Thomas S . Diagnosis and treatment of low back pain. BMJ. 2006; 332(7555):1430-4. PMC: 1479671. DOI: 10.1136/bmj.332.7555.1430. View

16.

Murdaca G, Colombo B, Puppo F . The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern Emerg Med. 2011; 6(6):487-95. DOI: 10.1007/s11739-011-0517-7. View

17.

Yang R, Chen Z, Cai J . Fecal microbiota transplantation: Emerging applications in autoimmune diseases. J Autoimmun. 2023; 141:103038. DOI: 10.1016/j.jaut.2023.103038. View

18.

Descalzi G, Ikegami D, Ushijima T, Nestler E, Zachariou V, Narita M . Epigenetic mechanisms of chronic pain. Trends Neurosci. 2015; 38(4):237-46. PMC: 4459752. DOI: 10.1016/j.tins.2015.02.001. View

19.

Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A . Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021; 53(2):156-165. PMC: 8515199. DOI: 10.1038/s41588-020-00763-1. View

20.

Slob E, Burgess S . A comparison of robust Mendelian randomization methods using summary data. Genet Epidemiol. 2020; 44(4):313-329. PMC: 7317850. DOI: 10.1002/gepi.22295. View